Bifidobacterium triple viable bacteria-assisted mirtazapine in gastric cancer postoperative rehabilitation

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

163

Figures (1-1)

Sum=204

Publishing Process of This Article

Item

Count

Browse

Download

Sum=176

Aug 27, 2025 (publication date) through Aug 28, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Surg. Aug 27, 2025; 17(8): 106860
Published online Aug 27, 2025. doi: 10.4240/wjgs.v17.i8.106860

Figure 1 Potential mechanisms of Bifidobacterium triple viable probiotics in treating postoperative depression in gastric cancer.

Citation: Li ZY, Liu ZC, Gao YN, Zhao Y, Bai CH, Xiao P, Wang DF, Cai HQ. Bifidobacterium triple viable bacteria-assisted mirtazapine in gastric cancer postoperative rehabilitation. World J Gastrointest Surg 2025; 17(8): 106860
URL: https://www.wjgnet.com/1948-9366/full/v17/i8/106860.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i8.106860